Generic Name: Brivaracetam
Brand Name: Brivlera
Manufacturer: UCB Canada Inc.
Therapeutic Area: Epilepsy, partial-onset seizures
Indications: Epilepsy, partial-onset seizures
Submission Type: Initial
Project Status: Complete
Date Recommendation Issued: January 25, 2017
Recommendation Type: Reimburse with clinical criteria and/or conditions